Memantine in moderate-to-severe Alzheimer disease evidence and ethics based?
Rikkert
Marcel G
MG
Dekkers
Wim J
WJ
Scheltens
Philip
P
Verhey
Frans
F
D000544:Alzheimer Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D023381:Endpoint Determination; D019317:Evidence-Based Medicine; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D018447:Medical Futility; D008559:Memantine / Q000627:therapeutic use*; D018579:Patient Selection; D012720:Severity of Illness Index
D018691:Excitatory Amino Acid Antagonists; D008559:Memantine